(Q53792929)

English

Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.

scientific article published in September 1983

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6871856

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6871856%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 October 2019

title

Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6871856

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6871856%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

0 references

Schorlemmer HU

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6871856

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6871856%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 October 2019

Bosslet K

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6871856

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6871856%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 October 2019

Sedlacek HH

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6871856

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6871856%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 October 2019

language of work or name

English

0 references

publication date

1 September 1983

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6871856

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6871856%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

Europe PubMed Central

PubMed publication ID

6871856

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6871856%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 October 2019

volume

43

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6871856

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6871856%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 October 2019

issue

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6871856

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6871856%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 October 2019

page(s)

4148-4153

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6871856

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6871856%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 October 2019

Identifiers

PubMed publication ID

6871856

1 reference

stated in

Europe PubMed Central

PubMed publication ID

6871856

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6871856%20AND%20SRC:MED&resulttype=core&format=json

(Q53792929)

Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)